Effect of Low-Dose Aspirin Use After Thermal Ablation in Patients with Hepatocellular Carcinoma: A Retrospective Study
Low-dose aspirin use was associated with better OS in patients with non-viral HCC after thermal ablation. In patients who received thermal ablation alone, the administration of low-dose aspirin could improve PFS. Aspirin use might be a protective factor in some patients after ablation.
Authors
- Shanshan Chen (ORCID: https://orcid.org/0000-0003-2160-0083)
- Liang Cai (ORCID: https://orcid.org/0000-0002-0746-4284)
- Xiaojun Wang (ORCID: https://orcid.org/0000-0003-2317-7821)
- Wei Li (ORCID: https://orcid.org/0000-0002-9991-7892)
- Long Cheng (ORCID: https://orcid.org/0000-0001-8333-2569)
- Yongchao Zhang (ORCID: https://orcid.org/0000-0001-8931-6738)
- Youjia Duan (ORCID: https://orcid.org/0000-0002-3534-8766)
- Xiaopu Hou
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- Beijing YouAn Hospital (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jhc.s435524
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74